Literature DB >> 18395150

Second primary cancers: an overview.

Andrea K Ng1, Lois B Travis.   

Abstract

Substantial improvements in the past few decades in cancer detection and supportive care along with advances in therapy have led to growing numbers of cancer survivors. In view of the prolongation of survival in increasing numbers of patients, identification and quantification of the late effects of cancer and its therapy have become critical. One of the most serious events experienced by cancer survivors is the diagnosis of a new cancer. The number of patients who have second or higher-order cancers is increasing, and solid tumors are a leading cause of mortality among several populations of long-term survivors, including patients who have Hodgkin lymphoma. The focus of this article is treatment-associated malignancies in survivors of selected adult cancers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18395150     DOI: 10.1016/j.hoc.2008.01.007

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  26 in total

1.  Economic burden of cancer survivorship among adults in the United States.

Authors:  Gery P Guy; Donatus U Ekwueme; K Robin Yabroff; Emily C Dowling; Chunyu Li; Juan L Rodriguez; Janet S de Moor; Katherine S Virgo
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

2.  Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck.

Authors:  Yang Zhang; Erich M Sturgis; Zhigang Huang; Mark E Zafereo; Qingyi Wei; Guojun Li
Journal:  Cancer       Date:  2011-06-29       Impact factor: 6.860

3.  A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer.

Authors:  Xiaoxiang Guan; Zhensheng Liu; Hongliang Liu; Hongping Yu; Li-E Wang; Erich M Sturgis; Guojun Li; Qingyi Wei
Journal:  FASEB J       Date:  2012-12-27       Impact factor: 5.191

4.  Annual patient time costs associated with medical care among cancer survivors in the United States.

Authors:  K Robin Yabroff; Gery P Guy; Donatus U Ekwueme; Timothy McNeel; Heather M Rozjabek; Emily Dowling; Chunyu Li; Katherine S Virgo
Journal:  Med Care       Date:  2014-07       Impact factor: 2.983

5.  Economic Burden of Chronic Conditions Among Survivors of Cancer in the United States.

Authors:  Gery P Guy; K Robin Yabroff; Donatus U Ekwueme; Sun Hee Rim; Rui Li; Lisa C Richardson
Journal:  J Clin Oncol       Date:  2017-05-04       Impact factor: 44.544

6.  Access to preventive health care for cancer survivors.

Authors:  K Robin Yabroff; Pamela F Short; Steven Machlin; Emily Dowling; Heather Rozjabek; Chunyu Li; Timothy McNeel; Donatus U Ekwueme; Katherine S Virgo
Journal:  Am J Prev Med       Date:  2013-09       Impact factor: 5.043

7.  Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck.

Authors:  Dapeng Lei; Erich M Sturgis; Zhensheng Liu; Mark E Zafereo; Qingyi Wei; Guojun Li
Journal:  Carcinogenesis       Date:  2009-12-02       Impact factor: 4.944

8.  Incident malignancies among older long-term breast cancer survivors and an age-matched and site-matched nonbreast cancer comparison group over 10 years of follow-up.

Authors:  Kerri M Clough-Gorr; Soe Soe Thwin; Jaclyn L F Bosco; Rebecca A Silliman; Diana S M Buist; Pamala A Pawloski; Virginia P Quinn; Marianne N Prout
Journal:  Cancer       Date:  2012-12-26       Impact factor: 6.860

9.  Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma.

Authors:  Navneet S Majhail; Ruta Bajorunaite; Hillard M Lazarus; Zhiwei Wang; John P Klein; Mei-Jie Zhang; J Douglas Rizzo
Journal:  Br J Haematol       Date:  2009-07-01       Impact factor: 6.998

10.  The Economics of Breast Cancer in Younger Women in the U.S.: The Present and Future.

Authors:  Donatus U Ekwueme; Justin G Trogdon
Journal:  Am J Prev Med       Date:  2016-02       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.